Data / Form D filings / Maxymune Therapeutics, Inc.
Maxymune Therapeutics, Inc.: Form D filings
Maxymune Therapeutics, Inc., a biotechnology company in Los Altos, CA, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on June 3, 2026, reports $2.7 million sold of a $4.5 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 95 MAIN ST. SUITE 9, Los Altos, CA, 94022
- Phone
- (650) 892-1942
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2058052
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Amendment | $4,500,000 | $2,675,000 | $1,825,000 | 15 | Feb 11, 2025 | sec.gov |
| Feb 28, 2025 | New notice | $2,500,000 | $850,000 | $1,650,000 | 8 | Feb 11, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gordon Ringold | Executive Officer, Director | |
| Neil Solomons | Director | |
| Tatjana Naranda | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Maxymune Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.